Alan G. Meehan
About
Alan G. Meehan is a scholar working on Endocrinology, Diabetes and Metabolism, Urology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Alan G. Meehan has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Urology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan G. Meehan's work include Hormonal and reproductive studies (13 papers), Urinary Bladder and Prostate Research (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Alan G. Meehan is often cited by papers focused on Hormonal and reproductive studies (13 papers), Urinary Bladder and Prostate Research (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Alan G. Meehan collaborates with scholars based in United States, Australia and Belgium. Alan G. Meehan's co-authors include Steven A. Kaplan, Arvind Shah, John W. Kusek, Claus G. Roehrborn, John D. McConnell, Leroy M. Nyberg, Joanne Waldstreicher, Jeannette Y. Lee, Yale Mitchel and J. Rotonda and has published in prestigious journals such as Annals of the New York Academy of Sciences, The Journal of Urology and The American Journal of Cardiology.
In The Last Decade
Alan G. Meehan
39 papers receiving 1.6k citations
Peers
Alan G. Meehan
Timothy H. Wilson United States
Bruce Bracken United States
Alice Taylor United States
Walter Krauwinkel Netherlands
Peter Langenstroer United States
Bimal Malhotra United States
Eric Grossman United States
D.P. Mikhailidis United Kingdom
B. M. Brenner United States
Thomas I‐Sheng Hwang Taiwan
Citations per year, relative to Alan G. Meehan Alan G. Meehan (= 1×)
peers
Timothy H. Wilson
Countries citing papers authored by Alan G. Meehan
Since
Specialization
Citations
This map shows the geographic impact of Alan G. Meehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Meehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Meehan more than expected).
Fields of papers citing papers by Alan G. Meehan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alan G. Meehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Meehan. The network helps show where Alan G. Meehan may publish in the future.
Co-authorship network of co-authors of Alan G. Meehan
This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Meehan. A scholar is included among the top collaborators of Alan G. Meehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Meehan. Alan G. Meehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Meehan, Alan G., et al.. (2023). Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Clinical Rheumatology. 42(12). 3397–3405.
2.
Meehan, Alan G., et al.. (2023). Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension Studies. Crohn s & Colitis 360. 5(3). otad044–otad044.
3.
Kaplan, Steven A., Jeannette Y. Lee, Edward A. O’Neill, Alan G. Meehan, & John W. Kusek. (2013). Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia. The Aging Male. 16(4). 169–172.
4.
Engel, Samuel S., Thomas Seck, Gregory T. Golm, et al.. (2013). Assessment of AACE/ACE Recommendations for Initial Dual Antihyperglycemic Therapy Using the Fixed-Dose Combination of Sitagliptin and Metformin Versus Metformin. Endocrine Practice. 19(5). 751–757.
5.
Bouloux, Pierre, Jean‐Jacques Legros, Jolanda M. H. Elbers, et al.. (2013). Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study. The Aging Male. 16(2). 38–47.
6.
Kaplan, Steven A., Edward A. O’Neill, Robert Lowe, Mary E. Hanson, & Alan G. Meehan. (2013). Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS). The Aging Male. 16(2). 48–51.
7.
Jones-Burton, Charlotte, Joseph Rubino, Sophie Roy, et al.. (2010). Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension. Journal of the American Society of Hypertension. 4(5). 219–226.
8.
Kaplan, Steven A., Jianxin Lin, Amy O. Johnson‐Levonas, Arvind Shah, & Alan G. Meehan. (2010). Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone. The Aging Male. 13(1). 40–43.
9.
Kaplan, Steven A., Claus G. Roehrborn, Alan G. Meehan, et al.. (2009). PCPT: Evidence That Finasteride Reduces Risk of Most Frequently Detected Intermediate- and High-grade (Gleason Score 6 and 7) Cancer. Urology. 73(5). 935–939.
10.
Kaplan, Steven A., Claus G. Roehrborn, John D. McConnell, et al.. (2008). Long-Term Treatment With Finasteride Results in a Clinically Significant Reduction in Total Prostate Volume Compared to Placebo Over the Full Range of Baseline Prostate Sizes in Men Enrolled in the MTOPS Trial. The Journal of Urology. 180(3). 1030–1033.
11.
Feldman, Theodore, Leiv Ose, Arvind Shah, et al.. (2007). Efficacy and Safety of Ezetimibe/Simvastatin Versus Simvastatin Monotherapy in Hypercholesterolemic Patients with Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 5(1). 13–21.
12.
Paolini, John F., Yale Mitchel, Robert Reyes, et al.. (2007). Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.. The American Journal of Cardiology. 101(5). 625–630.
13.
Extremera, Blas Gil, Gustavo Méndez, Alan G. Meehan, et al.. (2007). Efficacy and Safety of Ezetimibe/Simvastatin Co- Administered with Fenofibrate in Mixed Hyperlipidemic Patients with Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 5(4). 305–314.
14.
Feldman, Theodore, Michael H. Davidson, Arvind Shah, et al.. (2006). Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: A post Hoc analysis of subpopulations from three pooled clinical trials. Clinical Therapeutics. 28(6). 849–859.
15.
Crawford, E. David, Shandra Wilson, John D. McConnell, et al.. (2006). Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With Placebo. The Journal of Urology. 175(4). 1422–1427.
16.
Herman, Gary, Arthur Bergman, Fang Liu, et al.. (2006). Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects. The Journal of Clinical Pharmacology. 46(8). 876–886.
17.
Masana, L., Pedro Mata, Claude Gagné, et al.. (2005). Long-term safety and, tolerability profiles andlipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: A multicenter, randomized, double-blind, placebo-controlled, 48-week extension study. Clinical Therapeutics. 27(2). 174–184.
18.
Kaplan, Steven A., H. Logan Holtgrewe, Reginald C. Bruskewitz, et al.. (2001). Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia. Urology. 57(6). 1073–1077.
19.
Price, Vera H., Janet L. Roberts, Maria Hordinsky, et al.. (2000). Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. Journal of the American Academy of Dermatology. 43(5). 768–776.
20.
Meehan, Alan G., David Story, & Iain C. Medgett. (1987). Influence of the endothelium on the amplification by serotonin of vasoconstrictor responses to noradrenaline and sympathetic nerve stimulation in rabbit isolated ear artery. European Journal of Pharmacology. 141(3). 339–346.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Timothy H. Wilson Breakdown of academic impact, for papers by Bruce Bracken Breakdown of academic impact, for papers by Alice Taylor Breakdown of academic impact, for papers by Walter Krauwinkel Breakdown of academic impact, for papers by Peter Langenstroer Breakdown of academic impact, for papers by Bimal Malhotra Breakdown of academic impact, for papers by Eric Grossman Breakdown of academic impact, for papers by D.P. Mikhailidis Breakdown of academic impact, for papers by B. M. Brenner Breakdown of academic impact, for papers by Thomas I‐Sheng Hwang